Status:
TERMINATED
Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation
Lead Sponsor:
Tampere University Hospital
Conditions:
Neurobehavioral Manifestations
Atrial Fibrillation
Eligibility:
All Genders
50-70 years
Brief Summary
Atrial fibrillation is a common arrythmia. It is an independent risk factor for stroke. There for anticoagulation therapy is used for atrial fibrillation patients. Alternatively, left atrial appendix ...
Eligibility Criteria
Inclusion
- age 50-70
- undergoing left atrial catheter ablation or percutaneous left atrial appendix closure procedure
- In the ablation group, patients will qualify for the study if they have symptomatic atrial fibrillation (EHRA classification 2-4) and if their risk of thromboembolic complications with CHA2DS2VASc scale is low (0-2 points).
Exclusion
- Age under 18 or over 70 years.
- Contraindication for anticoagulation therapy (in ablation group),
- Previous neurological or psychiatric disorder.
- Significant visual problem that can't be corrected for,
- problems with upper arm/hand use, that would make the execution of the test difficult.
- normal contraindications for the ablation and appendix closure procedures.
Key Trial Info
Start Date :
February 9 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT02306460
Start Date
February 9 2015
End Date
December 1 2020
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Heart Hospital
Tampere, Finland, 33521